Ruben A. Ferrer, Manja Wobus, Catrin List, Rebekka Wehner, Claudia Schönefeldt, Barbara Brocard, Brigitte Mohr, Martina Rauner, Marc Schmitz, Maik Stiehler, Gerhard Ehninger, Lorenz C. Hofbauer, Martin Bornhäuser, Uwe Platzbecker. Mesenchymal stromal cells from patients with myelodyplastic syndrome display distinct functional alterations that are modulated by lenalidomide. haematol [Internet]. 2013Nov.1 [cited 2024Nov.25];98(11):1677-85. Available from: https://haematologica.org/article/view/6828